ProfileGDS4177 / 216859_x_at
TitleImatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1
OrganismHomo sapiens


KU-812 KCL-22 JURL-MK1 Imatinib untreated Imatinib untreated Imatinib untreated GSM603100 GSM603099 GSM603098 GSM603097 GSM603102 GSM603101 59% 60% 50% 46% 52% 53% sort by cell line sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM603100KU-812 Imatinib-treated50.7559
GSM603099KU-812 non-treated52.7860
GSM603098KCL-22 Imatinib-treated31.8150
GSM603097KCL-22 non-treated26.9746
GSM603102JURL-MK1 Imatinib-treated36.6852
GSM603101JURL-MK1 non-treated37.6553